Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Evinacumab Gets FDA Breakthrough Therapy Designation for Homozygous Familial Hypercholesterolemia

americanpharmaceuticalreviewApril 07, 2017

Tag: Regeneron Pharmaceuticals , hypercholesterolemia

PharmaSources Customer Service